tirzepatide first week weight loss beat semaglutide in the head to head trial., 72 weeks: 20.2% of body lost vs 13.7%. Waist down about 18 cm vs 13 cm (DOI: 10.1056/NEJMoa2416394)., Why: semaglutide hits one Tirzepatide Before and After Results:

Tirzepatide (TIRZ) is a synthetic dual agonist studied at both the GIP receptor and the GLP-1 receptor, making it a central focus in metabolic, incretin-pathway, and body-composition research

Prioritizing foods high in protein and fiber may help with blood sugar stabilization, muscle preservation, and keeping your gut moving

The study reviewed medical records, so researchers observed patterns

Do not exceed the recommended dosage.

This receptor functions as a tyrosine kinase that initiates intracellular growth cascades once activated

The medication works by activating both GIP and GLP-1 receptors, enhancing insulin secretion in a glucose-dependent manner, suppressing glucagon release, slowing gastric emptying, and reducing appetite